VKORC1 polymorphisms in Amerindian populations of Brazil

被引:14
作者
Perini, Jamila A. [1 ]
Petzl-Erler, Maria Luiza [2 ]
Tsuneto, Luiza Tamie [2 ]
Suarez-Kurtz, Guilherme [1 ]
机构
[1] Inst Nacl Canc, Div Farmacol, BR-20231050 Rio De Janeiro, Brazil
[2] Univ Fed Parana, Lab Genet Mol Human, BR-80060000 Curitiba, Parana, Brazil
关键词
Amerindian; anticoagulants; Brazil; Native American; VKORC1; warfarin;
D O I
10.2217/14622416.9.11.1623
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Noncoding polymorphisms in the VKORC1 gene associate with variation of interindividual dosing requirements of warfarin and other coumarin anticoagulants. The frequency of VKORC1 polymorphisms displays distinct interpopulation differences. Here, we report the distribution of the VKORC1 3673G>A, 5808T>G, 6853G>C and 9041G>A SNPs in three endogamous Amerindian (Native American) populations, namely, Guarani-Kaiowa, Guarani-Nandeva and Kaingang. Individual DNA from 180 healthy adults was genotyped for the VKORC1 polymorphisms using TaqMan (R) Detection System assays. The ARLEQUIN 3.1 software package was used to estimate haplotype frequency and linkage disequilibrium. The VKORC1 3673G>A, 5808T>G, 6853G>C and 9041G>A polymorphisms were in Hardy-Weinberg equilibrium in each population. The 5808G allele was absent or rare (<3%), whereas 3673A, 6853C and 9041A were frequent (34-63%) in the three Amerindian populations. No difference was detected in allele or genotype frequency bewteen the two Guarani populations, whereas significant differences were observed between Kaingang and Guarani. Polymorphisms 3673G>A, 6853G>C and 9041G>A were in significant linkage disequilibrium in both Guarani and Kaingang (pairwise r(2) values: 0.77-1.0). Haplotypes ATCG and GTGA accounted for more than 94% of the haplotypes in both populations, ATCG being the most common in Guarani (49.5%) and GTGA in Kaingang (54%). These data disclose the uniqueness of the frequency distribution of the VKORC1 SNPs in the Amerindians, compared with Asian, African and European populations. In view of the vast interpopulational diversity among Amerindians, the present data should not be interpreted as representative of other extant Amerindian peoples. Our estimates that 40% of Kaingang and 60% of Guarani have haplotypes including the variant 3673A allele suggest that these two Amerindian populations comprise high proportions of individuals requiring reduced warfarin doses.
引用
收藏
页码:1623 / 1629
页数:7
相关论文
共 28 条
[21]  
Salzano FM, 2002, EVOLUTION GENETICS L
[22]   Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians [J].
Schelleman, H. ;
Chen, Z. ;
Kealey, C. ;
Whitehead, A. S. ;
Christie, J. ;
Price, M. ;
Brensinger, C. M. ;
Newcomb, C. W. ;
Thorn, C. F. ;
Samaha, F. F. ;
Kimmel, S. E. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) :742-747
[23]   The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements:: proposal for a new dosing regimen [J].
Sconce, EA ;
Khan, TI ;
Wynne, HA ;
Avery, P ;
Monkhouse, L ;
King, BP ;
Wood, P ;
Kesteven, P ;
Daly, AK ;
Kamali, F .
BLOOD, 2005, 106 (07) :2329-2333
[24]  
Suarez-Kurtz G, 2007, PHARMACOGENOMICS ADM, P75
[25]   Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans [J].
Takahashi, Harumi ;
Wilkinson, Grant R. ;
Nutescu, Edith A. ;
Morita, Takashi ;
Ritchie, Marylyn D. ;
Scordo, Maria G. ;
Pengo, Vittorio ;
Barban, Martina ;
Padrini, Roberto ;
Ieiri, Ichiro ;
Otsubo, Kenji ;
Kashima, Toshitaka ;
Kimura, Sosuke ;
Kijima, Shinichi ;
Echizen, Hirotoshi .
PHARMACOGENETICS AND GENOMICS, 2006, 16 (02) :101-110
[26]   HLA class II diversity in seven Amerindian populations. Clues about the origins of the Ache [J].
Tsuneto, LT ;
Probst, CM ;
Hutz, MH ;
Salzano, FM ;
Rodriguez-Delfin, LA ;
Zago, MA ;
Hill, K ;
Hurtado, AM ;
Ribeiro-dos-Santos, AKC ;
Petzl-Erler, ML .
TISSUE ANTIGENS, 2003, 62 (06) :512-526
[27]   Common VKORC1 and GGCX polymorphisms associated with warfarin dose [J].
Wadelius, M ;
Chen, LY ;
Downes, K ;
Ghori, J ;
Hunt, S ;
Eriksson, N ;
Wallerman, O ;
Melhus, H ;
Wadelius, C ;
Bentley, D ;
Deloukas, P .
PHARMACOGENOMICS JOURNAL, 2005, 5 (04) :262-270
[28]   A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity [J].
Yuan, HY ;
Chen, JJ ;
Lee, MTM ;
Wung, JC ;
Chen, YF ;
Charng, MJ ;
Lu, MJ ;
Hung, CR ;
Wei, CY ;
Chen, CH ;
Wu, JY ;
Chen, YT .
HUMAN MOLECULAR GENETICS, 2005, 14 (13) :1745-1751